Altimmune Stock

Altimmune Intangible Assets

Intangible Assets of Altimmune (ALT) as of Sep 14, 2026.

Intangible Assets

0.00USD

Last updated:

Intangible Assets of Altimmune is 2026 0.00 USD. Intangible Assets of Altimmune was 2025 0.00 USD. It decreases by % lower compared to the previous year.

The Altimmune Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2018
13.90 M USD
Jan 1, 2019
12.70 M USD
Jan 1, 2020
12.80 M USD
Jan 1, 2021
12.40 M USD
Jan 1, 2022
12.40 M USD
Jan 1, 2023
0.00 USD
Jan 1, 2024
0.00 USD
Jan 1, 2025
0.00 USD
The Altimmune Intangible Assets history
YEARIntangible AssetsYoY
0.00USD—
0.00USD—
0.00USD-100.00%
12.40 MUSD0.00%
12.40 MUSD-3.13%
12.80 MUSD+0.79%
12.70 MUSD-8.63%
13.90 MUSD-64.08%
38.70 MUSD+158.00%
15.00 MUSD-33.32%
22.49 MUSD+857.85%
2.35 MUSD0.00%
2.35 MUSD0.00%
2.35 MUSD0.00%
2.35 MUSD0.00%
2.35 MUSD-27.71%
3.25 MUSD-4.54%
3.40 MUSD+161.76%
1.30 MUSD+8.33%
1.20 MUSD—
0.00USD—
Access this data via the Eulerpool API
Get Free API Key

Altimmune Stock analysis

What does Altimmune do? Altimmune Inc is a biopharmaceutical company specializing in the development of immunotherapies. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland, USA. Altimmune is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Altimmune stock

On Eulerpool you can find the complete historical development of Intangible Assets Altimmune since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's Altimmune historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Altimmune

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Altimmune